Tag: clotting

Medco to Include Genetics in Comparison of Anti-Clotting Drug Effectiveness

Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as the newer drug prasugrel (Effient™, Eli Lilly and Company) in people who lack a genetic variation that ...

Read more

More Evidence that Genetics Can Reduce the Efficacy of Anti-Clotting Medication Clopidogrel

A new report in the Journal of the American Medical Association adds to the mounting evidence that genetic variations impact the efficacy of clopidogrel (Plavix®), a drug used to prevent blood clots in people who have had a heart attack or stroke and also those with peripheral artery disease and unstable ...

Read more

Surgeon General Issues Call to Action on VTE: 23andMe Assesses Genetic Risk for Customers

This Monday acting Surgeon General Steven K. Galson issued a Call to Action to reduce the number of people in the United States affected by two serious blood clotting conditions: deep vein thrombosis and pulmonary embolism. Deep vein thrombosis (DVT), sometimes called “economy class syndrome” is the ...

Read more

Return to top